Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA.
Sports Med. 2011 Nov 1;41(11):949-66. doi: 10.2165/11591430-000000000-00000.
Since 2004, when the World Anti-Doping Agency assumed the responsibility for establishing and maintaining the list of prohibited substances and methods in sport (i.e. the Prohibited List), cannabinoids have been prohibited in all sports during competition. The basis for this prohibition can be found in the World Anti-Doping Code, which defines the three criteria used to consider banning a substance. In this context, we discuss the potential of cannabis to enhance sports performance, the risk it poses to the athlete's health and its violation of the spirit of sport. Although these compounds are prohibited in-competition only, we explain why the pharmacokinetics of their main psychoactive compound, Δ(9)-tetrahydrocannabinol, may complicate the results management of adverse analytical findings. Passive inhalation does not appear to be a plausible explanation for a positive test. Although the prohibition of cannabinoids in sports is one of the most controversial issues in anti-doping, in this review we stress the reasons behind this prohibition, with strong emphasis on the evolving knowledge of cannabinoid pharmacology.
自 2004 年世界反兴奋剂机构(WADA)承担建立和维护运动禁药清单(即禁用清单)的责任以来,大麻素在所有运动项目的比赛中均被禁止使用。这一禁令的依据可以在世界反兴奋剂条例中找到,该条例定义了用于考虑禁止一种物质的三个标准。在这种情况下,我们讨论了大麻素提高运动表现的潜力、它对运动员健康构成的风险以及它对体育精神的违背。尽管这些化合物仅在比赛中被禁止,但我们解释了为什么它们的主要精神活性化合物 Δ(9)-四氢大麻酚的药代动力学可能会使不良分析结果的结果管理复杂化。被动吸入似乎不是阳性测试的合理解释。虽然大麻素在运动中的禁用是反兴奋剂中最具争议的问题之一,但在本次综述中,我们强调了这一禁令背后的原因,并强烈强调了大麻素药理学的不断发展的知识。